A day in the life: Lance Hill, CEO at Within3
May 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A day in the life, Interview, Within3, feature
Could you give a short history of how you came to be in your current role? I’ve spent my entire …
Insider Interview: Paving paths in prostate cancer
May 16, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Interview, Janssen, feature, pharma, prostate cancer
Joaquin Casariego Garcia Luben, Medical Affairs Director Europe, Middle East & Africa, Prostate Cancer for Johnson & Johnson (pictured) discusses …
Pfizer’s abrocitinib smashes primary and secondary endpoints at Phase 3 in atopic dermatitis
May 16, 2019Research and Development Pfizer, abrocitinib, atopic dermatitis, pharma
Pfizer has lifted the curtain on new Phase 3 data for its Janus kinase 1 (JAK1) inhibitor abrocitinib, revealing that …
ImmunoGen shares plummet by 32% after FDA recommends new Phase 3 trial
May 16, 2019Business Services, Research and Development Cancer, Immunogen, Shares, ovarian cancer, pharma, stocks
Shares in ImmunoGen fell 32% in premarket trading after the firm said the FDA had recommended a new Phase 3 …
FDA greenlights Roche and AbbVie’s Venclexta for chronic lymphocytic leukaemia
May 16, 2019Sales and Marketing AbbVie, Cancer, FDA, Roche, Venclexta, leukaemia, pharma
Venclexta (venetoclax), the oral B-cell lymphoma-2 (BCL-2) inhibitor co-developed by AbbVie and Roche, has been approved by the FDA in …
Novartis’ Kymriah to be covered by Japan’s national insurance system
May 16, 2019Medical Communications, Sales and Marketing CAR T, CAR-T, Japan, Kymriah, Novartis, pharma
Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical …
J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs
May 16, 2019Manufacturing and Production Ireland, J&J, JJ, Limerick, medical technology, pharma
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care …
EUSA Pharma bolsters senior leadership team with two appointments
May 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eusa Pharma, appointment
Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two …
Paola Chiesi awarded honorary doctorate by Karolinska Institutet
May 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Paolo Chiesi, Vice President of the Chiesi Group, has been made an Honorary Doctor at the Karolinska Institutet – a …
Two Daiichi Sankyo drugs dealt a thumbs up and thumbs down by FDA advisory panel
May 15, 2019Research and Development, Sales and Marketing Daiichi Sankyo, FDA, pexidartinib, pharma, quizartinib
Daiichi Sankyo was left with a bittersweet taste in its mouth after it saw one of its drugs recommended for …
Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer
May 15, 2019Research and Development, Sales and Marketing FDA, Merck KGaA, Pfizer, inylta, pharma, renal cell carcinoma
The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). …
NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza
May 15, 2019Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …
Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says
May 15, 2019Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …
Medical Affairs 2025 – Excellence in the era of precision medicine
May 15, 2019Medical Communications, Research and Development pharma, veeva
Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its …
Ex-GSK, Novartis exec named as Mundipharma’s Head of Access
May 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma
Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …
Prophylactic antibiotic use could halve post-birth maternal infections, study indicates
May 14, 2019Manufacturing and Production, Research and Development Antibiotics, University of Oxford, pharma
A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all …
FDA expands indication for Eylea to cover all stages of diabetic retinopathy
May 14, 2019Manufacturing and Production Bayer, Eylea, FDA, Regeneron, approval, pharma
The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy. Regeneron chief scientific …
Mental health spending varies dramatically among regions in England, analysis shows
May 14, 2019Manufacturing and Production England, NHS, UK, mental health, mind, spending
Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …
MSD’s Keytruda recommended on NHS in Scotland for Stage 3 melanoma
May 14, 2019Manufacturing and Production, Sales and Marketing Cancer, MSD, Scotland, Scottish Medicines Consortium, keytruda, melanoma, pharma
MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC) …
Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says
May 14, 2019Manufacturing and Production China, US, USTR, pharma, tariffs, trade
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
